1-3 of 3
Jesús F. San-Miguel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma

Irene M. Ghobrial, Nicole Gormley, Shaji K. Kumar, Maria-Victoria Mateos, P. Leif Bergsagel, Marta Chesi, Madhav V. Dhodapkar, Angela Dispenzieri, Rafael Fonseca, Gad Getz, Efstathios Kastritis, Sigurdur Y. Kristinsson, Jose Angel Martinez-Climent, Salomon Manier, Catherine R. Marinac, Francesco Maura, Gareth J. Morgan, Faith E. Davies, Omar Nadeem, Mario Nuvolone, Bruno Paiva, Elizabeth O'Donnell, Felipe Prosper, Urvi A. Shah, Romanos Sklavenitis-Pistofidis, Adam S. Sperling, George S. Vassiliou, Nikhil C. Munshi, Philip E. Castle, Kenneth C. Anderson, Jesus F. San Miguel
Journal: Blood Cancer Discovery
Blood Cancer Discov (2024) 5 (3): 146–152.
https://doi.org/10.1158/2643-3230.BCD-24-0022
Published: 01 May 2024
View article titled, Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma
Open the PDF for Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma in another window
Journal Articles

Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel

Bruno Paiva, Irene Manrique, Julie Rytlewski, Timothy Campbell, Christian C. Kazanecki, Nathan Martin, Larry D. Anderson, Jr., Jesús G. Berdeja, Sagar Lonial, Noopur S. Raje, Yi Lin, Philippe Moreau, Jesús F. San-Miguel, Nikhil C. Munshi, Shari M. Kaiser
Journal: Blood Cancer Discovery
Blood Cancer Discov (2023) 4 (5): 365–373.
https://doi.org/10.1158/2643-3230.BCD-23-0044
Published: 01 September 2023
View article titled, Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel
Open the PDF for Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel in another window
Includes: Supplementary data
Journal Articles

Perspectives on the Risk-Stratified Treatment of Multiple Myeloma

Faith E. Davies, Charlotte Pawlyn, Saad Z. Usmani, Jesus F. San-Miguel, Hermann Einsele, Eileen M. Boyle, Jill Corre, Daniel Auclair, Hearn Jay Cho, Sagar Lonial, Pieter Sonneveld, A. Keith Stewart, P. Leif Bergsagel, Martin F. Kaiser, Katja Weisel, Jonathan J. Keats, Joseph R. Mikhael, Kathryn E. Morgan, Irene M. Ghobrial, Robert Z. Orlowski, C. Ola Landgren, Francesca Gay, Joseph Caers, Wee Joo Chng, Ajai Chari, Brian A. Walker, Shaji K. Kumar, Luciano J. Costa, Kenneth C. Anderson, Gareth J. Morgan
Journal: Blood Cancer Discovery
Blood Cancer Discov (2022) 3 (4): 273–284.
https://doi.org/10.1158/2643-3230.BCD-21-0205
Published: 06 July 2022
View article titled, Perspectives on the Risk-Stratified Treatment of Multiple Myeloma
Open the PDF for Perspectives on the Risk-Stratified Treatment of Multiple Myeloma in another window
Includes: Supplementary data